182 related articles for article (PubMed ID: 37894310)
1. TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer.
Katagata M; Okayama H; Nakajima S; Saito K; Sato T; Sakuma M; Fukai S; Endo E; Sakamoto W; Saito M; Saze Z; Momma T; Mimura K; Kono K
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894310
[TBL] [Abstract][Full Text] [Related]
2. A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer.
Endo E; Okayama H; Saito K; Nakajima S; Yamada L; Ujiie D; Kase K; Fujita S; Endo H; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
Mol Cancer Res; 2020 Sep; 18(9):1402-1413. PubMed ID: 32493700
[TBL] [Abstract][Full Text] [Related]
3. Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers.
Kim JH; Seo MK; Lee JA; Yoo SY; Oh HJ; Kang H; Cho NY; Bae JM; Kang GH; Kim S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903553
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
[TBL] [Abstract][Full Text] [Related]
5. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
[No Abstract] [Full Text] [Related]
6. TIM-3 Expression on Dendritic Cells in Colorectal Cancer.
Sakuma M; Katagata M; Okayama H; Nakajima S; Saito K; Sato T; Fukai S; Tsumuraya H; Onozawa H; Sakamoto W; Saito M; Saze Z; Momma T; Mimura K; Kono K
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791963
[TBL] [Abstract][Full Text] [Related]
7. Presence of Tim3
Klapholz M; Drage MG; Srivastava A; Anderson AC
J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
[TBL] [Abstract][Full Text] [Related]
9. Mucinous Colorectal Cancer is Associated With Expression of the TIM-3 Immune Checkpoint Independently of Microsatellite Instability (MSI) Status.
O'Connell E; Salvucci M; Reynolds IS; McNamara DA; Burke JP; Prehn JHM
Ann Surg Oncol; 2021 Nov; 28(12):7999-8006. PubMed ID: 33876348
[TBL] [Abstract][Full Text] [Related]
10. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.
Chen T; Li Q; Wu J; Wu Y; Peng W; Li H; Wang J; Tang X; Peng Y; Fu X
Cancer Immunol Immunother; 2018 Oct; 67(10):1635-1646. PubMed ID: 30121899
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K
Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303
[TBL] [Abstract][Full Text] [Related]
13. TGFβ and the Tumor Microenvironment in Colorectal Cancer.
Waldner MJ; Neurath MF
Cells; 2023 Apr; 12(8):. PubMed ID: 37190048
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of TIM-3 in circulation and tumor microenvironment of colorectal cancer patients.
Khalaf S; Toor SM; Murshed K; Kurer MA; Ahmed AA; Abu Nada M; Elkord E
Clin Immunol; 2020 Jun; 215():108429. PubMed ID: 32320745
[TBL] [Abstract][Full Text] [Related]
16. CXCL8 induces M2 macrophage polarization and inhibits CD8
Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
[TBL] [Abstract][Full Text] [Related]
17. Tim-3 facilitates immune escape in benzene-induced acute myeloid leukemia mouse model by promoting macrophage M2 polarization.
Ning Q; Jian T; Cui S; Shi L; Jian X; He X; Zhang X; Li X
Ecotoxicol Environ Saf; 2023 Nov; 266():115532. PubMed ID: 37806131
[TBL] [Abstract][Full Text] [Related]
18. Weighted Gene Co-expression Network Analysis Identifies CALD1 as a Biomarker Related to M2 Macrophages Infiltration in Stage III and IV Mismatch Repair-Proficient Colorectal Carcinoma.
Zheng H; Bai Y; Wang J; Chen S; Zhang J; Zhu J; Liu Y; Wang X
Front Mol Biosci; 2021; 8():649363. PubMed ID: 33996905
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic Profiling of Tumor-Infiltrating CD4
Sasidharan Nair V; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Soofi ME; Ouararhni K; Alajez NM; Abu Nada M; Elkord E
Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32041340
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
Daunke T; Beckinger S; Rahn S; Krüger S; Heckl S; Schäfer H; Wesch D; Pilarsky C; Eckstein M; Hartmann A; Röcken C; Wandmacher AM; Sebens S
Front Immunol; 2023; 14():1157397. PubMed ID: 37449210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
